ES2052105T3 - Gilanteno: principio anti-metastasico de sanguijuela de america del sur haementaria ghilianii. - Google Patents

Gilanteno: principio anti-metastasico de sanguijuela de america del sur haementaria ghilianii.

Info

Publication number
ES2052105T3
ES2052105T3 ES90111551T ES90111551T ES2052105T3 ES 2052105 T3 ES2052105 T3 ES 2052105T3 ES 90111551 T ES90111551 T ES 90111551T ES 90111551 T ES90111551 T ES 90111551T ES 2052105 T3 ES2052105 T3 ES 2052105T3
Authority
ES
Spain
Prior art keywords
ghilianii
sanguijuela
haementaria
gilanthene
metastatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90111551T
Other languages
English (en)
Inventor
Alan D Cardin
Sai Prasad Sunkara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2052105T3 publication Critical patent/ES2052105T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y10S530/856—Snakes; venom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y10S530/858—Proteins from animals other than mammals or birds insects; venom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Road Paving Structures (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

UN METODO PARA INHIBIR LA METATASIS DE UN TUMOR, UTILIZA LA ADMINISTRACION DE UN FACTOR ANTIMETASTASICO AISLADO DEL HAEMENTERIA GHILIANII.
ES90111551T 1989-06-20 1990-06-19 Gilanteno: principio anti-metastasico de sanguijuela de america del sur haementaria ghilianii. Expired - Lifetime ES2052105T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36861689A 1989-06-20 1989-06-20
US43836589A 1989-12-14 1989-12-14

Publications (1)

Publication Number Publication Date
ES2052105T3 true ES2052105T3 (es) 1994-07-01

Family

ID=27004258

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90111551T Expired - Lifetime ES2052105T3 (es) 1989-06-20 1990-06-19 Gilanteno: principio anti-metastasico de sanguijuela de america del sur haementaria ghilianii.

Country Status (10)

Country Link
US (1) US5447911A (es)
EP (1) EP0404055B1 (es)
JP (1) JP2947882B2 (es)
KR (1) KR0185973B1 (es)
AT (1) ATE102041T1 (es)
AU (1) AU624962B2 (es)
DE (1) DE69006931T2 (es)
DK (1) DK0404055T3 (es)
ES (1) ES2052105T3 (es)
IE (1) IE63540B1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2047527A1 (en) * 1990-07-24 1992-01-25 Christopher Dunwiddie Method for administering a therapeutic anticoagulant
NZ270194A (en) * 1994-01-07 1996-05-28 Ciba Geigy Ag Hirustasin, a serine protease inhibitor from hirudo medicinalis
EP0662514A1 (en) * 1994-01-07 1995-07-12 Ciba-Geigy Ag Hirustasin, an antistasin type serine proteinase inhibitor from Hiruda
TW586934B (en) * 1997-05-19 2004-05-11 Sumitomo Pharma Immunopotentiating composition
GB9930564D0 (en) 1999-12-23 2000-02-16 Evolutec Limited Screening method
US8004538B2 (en) 2007-09-21 2011-08-23 Global Oled Technology Llc Preferential tone scale for electronic displays
US8685462B1 (en) 2012-09-17 2014-04-01 Biopep Solutions, Inc. Whole, leech saliva product and applications thereof
JP2016529279A (ja) * 2013-08-29 2016-09-23 第一三共株式会社 がんの治療又は予防のための剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390630A (en) * 1980-10-28 1983-06-28 The Regents Of The University Of California Hementin--a fibrinolytic agent
US4588587A (en) * 1983-03-01 1986-05-13 Pennsylvania Hospital Method of treatment to inhibit metastasis
IL83912A (en) * 1986-09-18 1993-05-13 Pennsylvania Hospital Protein having anticoagulant and antimetastatic properties
US4832849A (en) * 1988-06-16 1989-05-23 Merrell Dow Pharmaceuticals Inc. Extraction and purification of an anticoagulant principle from the south american leech, haementeria ghilianii

Also Published As

Publication number Publication date
AU5753890A (en) 1991-01-03
IE902212L (en) 1990-12-20
AU624962B2 (en) 1992-06-25
US5447911A (en) 1995-09-05
KR0185973B1 (ko) 1999-05-01
KR910000172A (ko) 1991-01-29
JP2947882B2 (ja) 1999-09-13
DK0404055T3 (da) 1994-03-28
EP0404055B1 (en) 1994-03-02
EP0404055A1 (en) 1990-12-27
ATE102041T1 (de) 1994-03-15
JPH03128326A (ja) 1991-05-31
DE69006931D1 (de) 1994-04-07
IE63540B1 (en) 1995-05-17
DE69006931T2 (de) 1994-08-18
IE902212A1 (en) 1991-01-16

Similar Documents

Publication Publication Date Title
BR8801547A (pt) Conjunto de selo anular
ES509449A0 (es) "un procedimiento de preparacion de derivados de 1,3-dihidro-6-metil-7-hidroxi-furo-3,4-c-piridina".
IT8620860A0 (it) Procedimento per l'esercizio di un estrusore.
DE3870218D1 (de) Ringfoermige flanschverbindung.
NO871715L (no) Fremgangsmaate for fremstilling av alfa-olefinpolymer.
SE8902725D0 (sv) Centrifugalroer
NO168654C (no) Fremgangsmaate for polymerisering av 1,3-butadien.
ES2052105T3 (es) Gilanteno: principio anti-metastasico de sanguijuela de america del sur haementaria ghilianii.
GR76703B (es)
NO870177D0 (no) Fremgangsmaate for fremstilling av et soetemiddel.
ES511941A0 (es) "un procedimiento para la polimerizacion de un compuesto de eterglicidilico".
ES510628A0 (es) "un procedimiento mejorado de funcionamiento de un lecho fluidizado".
ES2113345T3 (es) Tratamiento de la disfuncion cardiaca con la ayuda de compuestos 15-ceto-prostaglandina.
IT8622436A0 (it) Procedimento di preparazione di unomo-o co-polimero del propilene.
FI860247A0 (fi) Foerfarande foer framstaellning av 4,4-dialkyl-2-azetidinoner.
ES2016263B3 (es) Inhibicion de la via de 5-lipoxigenasa.
NO158299C (no) Analogifremgangsmaate for fremstilling av 17, 18-dehydro-apovincaminol-l-3', 4', 5'-trimethoxy-benzoat.
TR23271A (tr) En asagi % 95.5 safliginda p-ksilol'un kazanilmasina mahsus usul
ES518725A0 (es) Procedimiento de preparacion de nuevos derivados del azabiciclo (3.2.0) heptano.
ES513723A0 (es) Un procedimiento para la preparacion de derivados de cistina".
ES510724A0 (es) "un procedimiento de preparacion de derivados de piridina".
NO862454D0 (no) Fremgangsmaate for behandling av peroxydblekeavluter.
ES548964A0 (es) Un procedimiento de preparacion del 2,6-dimetil-5-metoxicar-bonil-4-(3-nitrofenil)-1,4-dihidropiridina-3-carboxilato de etilo
ES549302A0 (es) Un procedimiento de preparacion del 2,6-dimetil-5-metoxicar-bonil-4-(2-nitrofenil)-1,4-dihidropiridina-3-carboxilato de isobutilo
ES548683A0 (es) Procedimiento de preparacion de un derivado del 2,3-dihidro-2-oxoindol

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 404055

Country of ref document: ES